New Cardioviva probiotic supplement available across Canada and US
The new supplement comes at a time when scientific and public health leaders are conducting several studies to understand the role of microbiome, known as the gut, in
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.